Tag: psychedelics
-
![MYND Life Sciences (MYND.C) provides unorthodox route to better mental health]()
MYND Life Sciences (MYND.C) provides unorthodox route to better mental health
We’re living in interesting times and I mean that in the Chinese curse kind of way. We can’t seem to stop to catch our breath when it comes to this pandemic, and the news sources we trust to keep us informed can’t seem to get the story straight. The result is more isolation, frustration, and…
-
![Filament Health (FH.NEO): fighting the good fight against anxiety and depression]()
Filament Health (FH.NEO): fighting the good fight against anxiety and depression
You’d be hard pressed to find someone who hasn’t been touched by depression or anxiety. Biochemically, they’re considered co-morbid, which means they often happen at the same time and feed off of one another. Depression and anxiety often overlap in terms of neurotransmitters and therefore, they’re often lumped together and treated the same way. And…
-
![Filament Health (FH.NEO) brings an all natural option to fight depression and anxiety]()
Filament Health (FH.NEO) brings an all natural option to fight depression and anxiety
You’d be hard pressed to find someone who hasn’t been touched by depression or anxiety. Biochemically, they’re considered co-morbid, which means they often happen at the same time and feed off of one another. Depression and anxiety often overlap in terms of neurotransmitters and therefore, they’re often lumped together and treated the same way. And…
-
![Today’s Idea: Revive Therapeutics (RVV.C) offers treatments for a mixed-bag of diseases, but the upside is all yours]()
Today’s Idea: Revive Therapeutics (RVV.C) offers treatments for a mixed-bag of diseases, but the upside is all yours
We’re closing in on three years now and it’s becoming hard to believe there was a market before COVID-19. We can barely remember it. Cannabis was a thing briefly, and before that we had crypto, and after cannabis’ untimely deflation in the summer of 2018, we were looking for the next source of market exuberance.…
-
Psychedelic Weekly Roundup with MNMD.Q, MSET.C, MYND.C, MEDI.NE, AWKN.NE, SILO, MCUR.C, NOVA.C, TRYP.C, TPIA, NEON.C
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine (MNMD.Q, MMED.NE) MindMed announced that they have agreed to partner with Forian (FORA.Q), who provide evidence-based support for clinical and commercial decision making. Forian and MindMed will collaborate to…
-
![Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor]()
Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor
Filament Health (FH.NE) to release their unaudited financial results for the second quarter of 2021, a period that ended June 30, 2021. As of June 30, Filament had $7.8 million in cash and cash equivalents. This includes $5 million which was raised through a private placement that closed on June 21. That private placement included…
-
![Cybin (CYBN.NE) Closes Overnight Public Offering, Fortifies Cash Balance]()
Cybin (CYBN.NE) Closes Overnight Public Offering, Fortifies Cash Balance
Cybin (CYBN.NE) announced today that it has closed its previously announced overnight marketed offering including the exercise in full of the over-allotment option granted to the Underwriters. “Investor demand for this financing was very strong and we are thankful for the outstanding work of our banking syndicate partners and advisors and we welcome all new…
-
Cybin (CYBN.NEO): Grown up approach to psychedelics brings half billion valuation… so far
Back in January of this year, we told you about a psychedelics company that was going to come at that sector like many had talked about, but few had achieved. Their angle? Be a biotech company. Don’t dick about with fakey business plans or black velvet paintings of Elvis. No Jamaican B&Bs dressed up as…
-
![Cybin (CYBN.E) new tryptamine patent improves outcome quality]()
Cybin (CYBN.E) new tryptamine patent improves outcome quality
Cybin (CYBN.E) filed a new provisional patent application for its ongoing drug candidate programs today, according to a press release. The application includes compositions which the company anticipates will improve pharmacokinetic profiles while keeping efficacy measures of the original molecules. The company’s patent also offers new delivery systems to increase onset of Cybin’s psychedelic tryptamine,…
-
Delic Holdings (DELC.C) asked to justify promo materials but, to be honest, the materials are good
At Equity.Guru, engaged as we are in market awareness programs for public companies, we often see competing entities that are more promotional than journalistic, banging out borderline insanity regarding their client companies and how they’re all the best thing ever. And when we see something egregious, we’re often the first ones to point it out.…
